Molnupiravir - Wikipedia Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses [6] It is used to treat COVID‑19 in those infected by SARS-CoV-2 [6]
9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill A new pill from Merck called molnupiravir could be game-changer in the battle against COVID-19 The company reported that the drug cut the risk of hospitalization and death by half in patients who had mild-to-moderate COVID-19
Molnupiravir (oral route) - Mayo Clinic Molnupiravir is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death) or in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate
Lagevrio vs. Paxlovid: Comparing COVID-19 Pills - GoodRx Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir ritonavir) are two oral antiviral treatments that are available for mild to moderate COVID-19 These COVID pills are only recommended for people with a high risk of developing severe illness
Molnupiravir: MedlinePlus Drug Information Molnupiravir is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in adults who have mild to moderate symptoms and are at risk of severe disease that could result in hospitalization or death when other treatments are either not available or cannot be used
About molnupiravir - NHS Molnupiravir is an antiviral medicine that works by stopping the virus that causes COVID-19 from growing and spreading It's used to treat early COVID-19 infection and help to prevent more severe symptoms
Information for Patients | LAGEVRIO™ (molnupiravir) LAGEVRIO™ (molnupiravir) is an investigational medicine used to treat adults with mild-to-moderate COVID-19: who are at risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate